A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen

Investigator: Kershaw Patel, MD

Study Coordinator: Iris Alanis

Status: Enrolling

ClinicalTrials.gov Number: NCT05769608

Phone: 713.441.6548

Protocol Number: PRO00037712


A Phase 2 trial to evaluate the blood pressure-lowering effect of lorundrostat (an aldosterone synthase inhibitor), administered on a background of a standardized anti-hypertensive (AHT) medication regimen, in subjects with uncontrolled and/or treatment-resistant hypertension.
More to Explore